Related Experiment Video
Updated: Jun 14, 2026
04:36
An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Diabetic retinal disease: Five trials to watch
Hannah Khan1, Aamir A Aziz2, Arshad M Khanani3
1University of Nevada, Reno School of Medicine, Reno, NV, USA.
Med (New York, N.Y.)
|June 12, 2026
Summary
Diabetic retinal disease causes vision loss, but new treatments like topical therapies and gene therapy are being developed. These aim for earlier, personalized, and long-lasting disease management, moving beyond frequent injections.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Diabetic Retinopathy
Background:
- Diabetic retinal disease is a primary cause of vision loss.
- Current treatments involve frequent injections, leading to poor patient adherence.
- There is a need for improved therapeutic strategies.
Purpose of the Study:
- To review emerging alternative treatments for diabetic retinal disease.
- To highlight the shift towards more personalized and durable therapeutic approaches.
- To discuss advancements beyond current standard treatments.
Main Methods:
- Review of ongoing clinical trials.
- Evaluation of novel therapeutic modalities including topical therapies, sustained delivery systems, and gene therapy.
- Analysis of the evolving landscape of diabetic retinal disease management.
Main Results:
- Several alternative treatments are under investigation.
- Topical therapies, sustained delivery systems, and gene therapy show promise.
- The field is moving towards earlier intervention and disease modification.
Conclusions:
- New therapeutic avenues are emerging for diabetic retinal disease.
- The future of treatment focuses on personalized, sustained, and disease-modifying strategies.
- These advancements aim to overcome limitations of current treatments and improve patient outcomes.
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...